Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis

BACKGROUND: In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid plus rifampicin for 4 months (4HR) instead of 6HE. We compared the impact of a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Manabe, Yukari C., Hermans, Sabine M., Lamorde, Mohammed, Castelnuovo, Barbara, Mullins, C. Daniel, Kuznik, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377630/
https://www.ncbi.nlm.nih.gov/pubmed/22723960
http://dx.doi.org/10.1371/journal.pone.0039187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377630/
https://www.ncbi.nlm.nih.gov/pubmed/22723960
http://dx.doi.org/10.1371/journal.pone.0039187

Ejemplares similares